WebMar 18, 2016 · On March 16, 2016, the U.S. Commodity Futures Trading Commission (“CFTC”) unanimously voted to approve a final amendment (the “Amendment”) to the trade option exemption for the benefit of commercial end users of commodity trade options that are not swap dealers (“SD”) or major swap participants (“MSP”) (referred to hereafter as … Web11 rows · Commodity Futures Trading Commission CFTC
CFTC Provides Exemptive Relief for Commodity Pool Operators …
Web7 hours ago · The Commodity Futures Trading Commission (CFTC or Commission) is announcing an opportunity for public comment on the proposed renewal of a collection of certain information by the agency. Under the Paperwork Reduction Act (PRA), Federal agencies are required to publish notice in the Federal... WebPage 8 of 14 3.2 Volume threshold account identification The Exchange will require the information below for identification of a Volume Threshold Account. The manner and format in which the identifying information should be submitted is the same as a CFTC Form 102B. Any no-action relief granted by the CFTC for a specific bionext lab mersch
RE: REQUEST FOR NO-ACTION LETTER REGARDING THE …
WebNov 13, 2024 · The overarching goal of the CFTC’s proposal is to simplify and modernize those regulations by codifying (and, in certain respects, expanding upon) relief in long-standing CFTC staff advisories and no-action letters. 2 Registration Exemption for CPOs Operating in Multiple Jurisdictions Web1 day ago · A series of civil unrest incidents began in France on 19 January 2024, organised by opponents of the pension reform bill proposed by the Borne government, which would increase the retirement age from 62 to 64 years old. The strikes have led to widespread disruption, including garbage piling up in the streets and public transport cancellations. In … Web1 See CFTC Letter No. 14-112 (Sept. 8, 2014). 2 See CFTC Letter No. 13-51 (Sept. 5, 2013). ... notes that the relief provided under the Letter will expire upon future rulemaking or other CFTC action relating to the underlying subject matter thereof. We will continue to monitor and report on developments in this area. *** Authors: bionext steinfort